News | April 05, 2023
Israeli researchers develop an effective drug to prevent muscle diseases
The disease is caused by a mutation in the gene encoding HMG CoA reductase, inhibiting the enzyme’s activity.
The disease is caused by a mutation in the gene encoding HMG CoA reductase, inhibiting the enzyme’s activity.
Vikas Vij has been appointed as Chief Executive Officer (CEO) of the company
Licences should enable potentially millions of people living in areas most impacted by HIV to access this innovative prevention medicine through low-cost generic manufacturers
Loperamide Hydrochloride Capsules USP, 2 mg had annual sales of US $34.7 million in the United States
Pre-filled pens containing a combination of insulin glargine 100 Units/mL and lixisenatide for once-daily dosing
hubergroup’s two newly added medical vans are dedicated to dental and eye care
Women of all ages will get round-the-clock access to comprehensive treatment
ZYIL1 is a novel oral small molecule NLRP3 inhibitor which has demonstrated CSF penetration in non-human primates
Rocuronium Bromide Injection had an annual sale of approximately US $53 million in the US (IQVIA MAT December 2022)
The antiviral is efficacious in non-human primates, and is safe and well-tolerated in humans
Subscribe To Our Newsletter & Stay Updated
